---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-130440"
form_type: "8-K"
ticker: null
cik: "0001082038"
company_name: "DURECT CORP"
filed_at: "2024-11-25T23:59:59+00:00"
generated_at: "2026-05-29T18:36:54.733045+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# DURECT sells ALZET product line for $17.5M, pays off Oxford term loan

## Summary
- Transaction valued at $17.5M; DURECT paid off all remaining Oxford Finance LLC term loan obligations.
- Proceeds extend cash runway through first half of 2025; focus on larsucosterol Phase 3 trial for AH.
- ALZET osmotic pumps acquired by Alzet, LLC, a subsidiary of Lafayette Instrument Co. (Branford Castle portfolio).
- Transition services agreement for up to six months post-closing; Aquilo Partners acted as financial advisor.

## SEC filing metadata
- accession: 0000950170-24-130440
- form_type: 8-K
- cik: 0001082038
- company_name: DURECT CORP
- filed_at: 2024-11-25T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1082038/000095017024130440/0000950170-24-130440-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1082038/000095017024130440/drrx-20241122.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-130440
- JSON: https://secwatch.observer/filing/0000950170-24-130440.json
- Plain text: https://secwatch.observer/filing/0000950170-24-130440.txt

## Key facts
- M&A Transactions
  DURECT CORP completed a disposition involving Alzet, LLC, a subsidiary of Lafayette Instrument Co. for $17,500,000 (closed 2024-11-22).
  - Action: disposition
  - Counterparty: Alzet, LLC, a subsidiary of Lafayette Instrument Co.
  - Consideration: $17,500,000
  - Closing: 2024-11-22
  source text: to potential extensions. On the Closing Date, the Company completed the transaction contemplated by the APA. Pursuant to the terms of the APA, the Purchaser paid the Company $17,500,000 subject to certain adjustments, including for net working capital. Simultaneous with this transaction, the Company has paid off all remaining obligations under the term loan
  evidence_url: https://www.sec.gov/Archives/edgar/data/1082038/000095017024130440/0000950170-24-130440-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.